Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

RXi acquires worldwide license for vaccine candidate targeting gynecological cancers

Sep. 23, 2011

BMS and Ambrx establish partnership for biologics

Sep. 23, 2011

Ariel Pharmaceuticals in-licenses lead product for acute migraine from BTG

Sep. 22, 2011

Bristol-Myers Squibb and Ono enter agreement for Orencia and BMS-936558/ONO-4538

Sep. 22, 2011

Sanofi Pasteur and UC San Diego to collaborate on immunological approach to acne

Sep. 21, 2011

Max-Planck-Gesellschaft and Sanofi partnership aims at restoring vision

Sep. 20, 2011

Aestus Therapeutics to develop in-licensed Prosidion product for new indication

Sep. 20, 2011

Sanofi transfers Hyalgan rights back to Fidia Farmaceutici

Sep. 20, 2011

Merck KGaA acquires exclusive worldwide rights to experimental MS treatment

Sep. 19, 2011

Eisai enters collaboration with SFJ to conduct phase III E-7080 trials

Sep. 15, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...